| dc.creator | Pascarella, Stefano | |
| dc.creator | Bianchi, Martina | |
| dc.creator | Giovanetti, Marta | |
| dc.creator | Narzi, Daniele | |
| dc.creator | Cauda, Roberto | |
| dc.creator | Cassone, Antonio | |
| dc.creator | Ciccozzi, Massimo | |
| dc.date | 2022-12-23T14:39:11Z | |
| dc.date | 2022-12-23T14:39:11Z | |
| dc.date | 2022 | |
| dc.date.accessioned | 2023-09-26T22:15:09Z | |
| dc.date.available | 2023-09-26T22:15:09Z | |
| dc.identifier | PASCARELLA, Stefano et al. The SARS‐CoV‐2 Mu variant should not be left aside: It warrants attention for its immuno-escaping ability. Journal of Medical Virology, v. 94, p. 2479-2486, 2022. | |
| dc.identifier | 1096-9071 | |
| dc.identifier | https://www.arca.fiocruz.br/handle/icict/56188 | |
| dc.identifier | 10.1002/jmv.27663 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8876862 | |
| dc.description | The COVID‐19 pandemic continues to have a threatening impact on a global scale,
largely due to the emergence of newly SARS‐CoV‐2 variants. The Mu (PANGO
lineage B.1.621), was first identified in Colombia in January 2021 and was classified
as a variant of interest (VOI) in August 2021, due to a constellation of mutations that
likely‐mediate an unexpectedly enhanced immune resistance to inactivated vaccineelicited
antibodies. Despite recent studies suggesting that the Mu variant appears to
have less infectivity than the Delta variant, here we examined the structural effect of
the Mu spike protein mutations and predicted the potential impact on infectivity of
the Mu variant compared with the Delta and Delta plus spike protein. | |
| dc.format | application/pdf | |
| dc.language | eng | |
| dc.publisher | Wiley | |
| dc.rights | open access | |
| dc.subject | Variação antigênica | |
| dc.subject | SARS coronavírus | |
| dc.subject | Bioestatística e Bioinformática | |
| dc.subject | Genética | |
| dc.subject | Classificação de vírus | |
| dc.subject | Antigenic variation | |
| dc.subject | Biostatistics & Bioinformatics | |
| dc.subject | Genetics | |
| dc.subject | SARS coronavirus | |
| dc.subject | Virus classification | |
| dc.title | The SARS‐CoV‐2Mu variant should not be left aside: It warrants attention for its immuno‐escaping ability | |
| dc.type | Article | |
